New combo therapy aims to calm face pain attacks
NCT ID NCT07596485
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests whether an injection of RP-008 followed by a daily varenicline pill is safe and can reduce pain for people with trigeminal neuralgia, a condition causing severe facial pain attacks. About 24 adults aged 18-80 with classic or idiopathic trigeminal neuralgia will receive the treatment. The main goal is to check safety and see if pain attacks become less frequent or severe.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIGEMINAL NEURALGIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Kriya Clinical Study Site
RECRUITINGSherbrooke, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Pain relief showdown: one drug vs. two for facial nerve pain
- Laser showdown: which light therapy zaps facial pain best?
- Massive study aims to predict brain surgery success
- Magnetic pulses to the brain may ease stubborn nerve pain
- AI and VR join forces to fight severe facial pain
- Teflon placement in brain surgery may affect pain return